Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV. [electronic resource] by
- Payer, B A
- Reiberger, T
- Breitenecker, F
- Aichelburg, M C
- Schuster, C
- Heil, P M
- Scherzer, T M
- Ferenci, P
- Rieger, A
- Peck-Radosavljevic, M
Producer: 20121024
In:
The Journal of infection vol. 65
Availability: No items available.
|
|
6.
|
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. [electronic resource] by
- Rutter, K
- Hofer, H
- Beinhardt, S
- Dulic, M
- Gschwantler, M
- Maieron, A
- Laferl, H
- Stättermayer, A F
- Scherzer, T-M
- Strassl, R
- Holzmann, H
- Steindl-Munda, P
- Ferenci, P
Producer: 20140128
In:
Alimentary pharmacology & therapeutics vol. 38
Availability: No items available.
|
|
7.
|
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. [electronic resource] by
- Stättermayer, A F
- Strassl, R
- Maieron, A
- Rutter, K
- Stauber, R
- Strasser, M
- Beinhardt, S
- Datz, C
- Scherzer, T-M
- Steindl-Munda, P
- Gschwantler, M
- Trauner, M
- Hofer, H
- Ferenci, P
Producer: 20141007
In:
Alimentary pharmacology & therapeutics vol. 39
Availability: No items available.
|